Ovarian Microcystic Stromal Tumor: A Rare Clinical Manifestation of Familial Adenomatous Polyposis. (November 2016)

• Record Type: Journal Article
• Authors: Liu, Cheng; Gallagher, Renee L.; Price, Gareth R.; Bolton, Elizabeth; Joy, Christopher; Harraway, James; Venter, Deon J.; Armes, Jane E.
• Is Part Of: International journal of gynecological pathology. Volume 35:Number 6(2016)
• Publication Date: 2016-11
• Subjects: Microcystic stromal tumor -- Familial adenomatous polyposis -- β-catenin -- APC -- FANCD2; Gynecologic pathology -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Diseases -- Periodicals; 618.10705
• DOI: 10.1097/PGP.0000000000000289
• Languages: English
• ISSNs: 0277-1691

Abstract

Abstract : Microcystic stromal tumor (MST) is a rare tumor of presumed sex-cord stromal differentiation. We present a case of MST arising within a patient with constitutional 5q deletion syndrome, whose deletion encompassed the APC gene. Genomic analysis of the MST revealed a point mutation in the remaining APC allele, predicted to result in abnormal splicing of Exon 7. Subsequent clinical investigation revealed multiple gastrointestinal polyps qualifying for a diagnosis of familial adenomatous polyposis. This case emphasizes the importance of an aberrant Wnt/β-catenin pathway in the development of MST and adds credence to the inclusion of MST as a rare phenotype of familial adenomatous polyposis. In a search for additional genetic aberrations which may contribute to the development of this rare tumor, genomic analysis revealed a frameshift mutation in FANCD2, a protein which plays a key role in DNA repair. This protein is expressed in human ovarian stromal cells and FANCD2 -knockout mice are known to develop sex cord-stromal tumors, factors which further support a possible role of aberrant FANCD2 in the development of MST. Abstract : Supplemental Digital Content is available in the text.